Zobrazeno 1 - 10
of 146
pro vyhledávání: '"Geiguer, F."'
Autor:
Grolleau E; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Pulmonology Department, Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France., Candiracci J; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium., Lescuyer G; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Barthelemy D; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Benzerdjeb N; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Pathology Department, Claude Bernard University Lyon I, Hospices Civils de Lyon, 69677 Bron, France., Haon C; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Geiguer F; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Raffin M; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Hardat N; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium., Balandier J; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Rabeuf R; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium., Chalabreysse L; Pathology Department, Claude Bernard University Lyon I, Hospices Civils de Lyon, 69677 Bron, France., Wozny AS; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France., Rommelaere G; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium., Rodriguez-Lafrasse C; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France., Subtil F; Statistic Department, Hospices Civils de Lyon, 69008 Lyon, France.; LBBE, Claude Bernard University Lyon I, UMR 5558, CNRS, 69100 Villeurbanne, France., Couraud S; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Pulmonology Department, Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France., Herzog M; Belgian Volition SRL, Parc Scientifique Créalys, 5032 Isnes, Belgium., Payen-Gay L; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Institute of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard University Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Publikováno v:
Biomolecules [Biomolecules] 2023 Aug 16; Vol. 13 (8). Date of Electronic Publication: 2023 Aug 16.
Autor:
Garcia J; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France., Gauthier A; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Lescuyer G; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France., Barthelemy D; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France., Geiguer F; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France., Balandier J; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France., Edelstein DL; Life Sciences Medical Affairs and Research and Development Sysmex Inostics, GmBH, Hamburg, Germany., Jones FS; Life Sciences Medical Affairs and Research and Development Sysmex Inostics, GmBH, Hamburg, Germany., Holtrup F; Life Sciences Medical Affairs and Research and Development Sysmex Inostics, GmBH, Hamburg, Germany., Duruisseau M; Service de Pneumologie, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France., Grolleau E; Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Groupement Hospitalier Sud, Institut de Cancérologie des Hospices Civils de Lyon, Pierre-Bénite, France., Rodriguez-Lafrasse C; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Merle P; Service de Pneumologie, Centre Hospitalier Gabriel Montpied, Clermont-Ferrand, France., Couraud S; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France.; Service de Pneumologie Aigue Spécialisée et Cancérologie Thoracique, Groupement Hospitalier Sud, Institut de Cancérologie des Hospices Civils de Lyon, Pierre-Bénite, France.; EMR 3738 Ciblage Thérapeutique en Oncologie, Faculté de Médecine Lyon-Sud, Université de Lyon, Oullins, France., Payen L; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre-Bénite, France. Lea.payen-gay@chu-lyon.fr.; Hospices Civils de Lyon Cancer Institute, CIRculating CANcer (CIRCAN) Program, Pierre-Bénite, France. Lea.payen-gay@chu-lyon.fr.; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495, Pierre-Bénite, France. Lea.payen-gay@chu-lyon.fr.
Publikováno v:
Molecular diagnosis & therapy [Mol Diagn Ther] 2021 Mar; Vol. 25 (2), pp. 239-250. Date of Electronic Publication: 2021 Mar 03.
Autor:
Barthelemy D; Institut of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Lescuyer G; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Geiguer F; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Grolleau E; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.; Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon 1, 69921 Oullins, France.; Acute Respiratory Disease and Thoracic Oncology, Pneumology Department of Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France., Gauthier A; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France., Balandier J; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Raffin M; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France., Bardel C; Institut of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard Lyon I, 69373 Lyon, France.; Department of Bioinformatics, Hospices Civils de Lyon, 69008 Lyon, France., Bouyssounouse B; INOVOTION, 38700 La Tronche, France., Rodriguez-Lafrasse C; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France., Couraud S; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.; Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon 1, 69921 Oullins, France.; Acute Respiratory Disease and Thoracic Oncology, Pneumology Department of Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France., Wozny AS; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Cellular and Molecular Radiobiology Laboratory UMR CNRS5822/IP2I, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France., Payen L; Institut of Pharmaceutical and Biological Sciences (ISPB), Claude Bernard Lyon I, 69373 Lyon, France.; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Center for Innovation in Cancerology of Lyon (CICLY) EA 3738, Faculty of Medicine and Maieutic Lyon Sud, Claude Bernard University Lyon I, 69921 Oullins, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre-Bénite, France.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Mar 03; Vol. 15 (5). Date of Electronic Publication: 2023 Mar 03.
Autor:
Rousset X; INOVOTION, 38700 La Tronche, France., Maillet D; University Claude Bernard Lyon, 69100 Villeurbanne, France.; Department of Medical Oncology, Lyon Sud Hospital, Hospices Civils de Lyon, 69310 Pierre-Bénite, France.; Centre de Recherche en Cancérologie de Lyon, INSERM 1052 CNRS UMR 5286, 69008 Lyon, France., Grolleau E; University Claude Bernard Lyon, 69100 Villeurbanne, France.; Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon, 69310 Pierre-Bénite, France.; EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, 69000 Lyon, France., Barthelemy D; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre Bénite, France., Calattini S; Clinical Research Plateform, Institut de Cancérologie des Hospices Civils de Lyon, 69002 Lyon, France., Brevet M; Department of Pathology, Lyon Est Hospital, Hospices Civils de Lyon, 69677 Bron, France., Balandier J; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre Bénite, France., Raffin M; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre Bénite, France., Geiguer F; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre Bénite, France., Garcia J; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre Bénite, France., Decaussin-Petrucci M; University Claude Bernard Lyon, 69100 Villeurbanne, France.; EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, 69000 Lyon, France.; Department of Pathology, Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France., Peron J; University Claude Bernard Lyon, 69100 Villeurbanne, France.; Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique-Santé, CNRS UMR 5558, Université Claude Bernard Lyon 1, 69100 Villeurbanne, France., Benzerdjeb N; University Claude Bernard Lyon, 69100 Villeurbanne, France.; EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, 69000 Lyon, France.; Department of Pathology, Lyon Sud Hospital, Hospices Civils de Lyon, 69495 Pierre-Bénite, France., Couraud S; University Claude Bernard Lyon, 69100 Villeurbanne, France.; Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon, 69310 Pierre-Bénite, France.; EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, 69000 Lyon, France., Viallet J; INOVOTION, 38700 La Tronche, France., Payen L; University Claude Bernard Lyon, 69100 Villeurbanne, France.; EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, 69000 Lyon, France.; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495 Pierre-Bénite, France.; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon, Cancer Institute, 69495 Pierre Bénite, France.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Aug 23; Vol. 14 (17). Date of Electronic Publication: 2022 Aug 23.
Autor:
Kara, N., Descotes, F., Decaussin Petrucci, M., Piaton, E., Geiguer, F., Rodriguez-Lafrasse, C., Terrier, J.E., Lopez, J., Ruffion, A.
Publikováno v:
In European Urology Supplements March 2017 16(3):e195-e197
Autor:
Garcia J; Laboratoire de Biochimie Et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495, Pierre Bénite, France.; CIRculating CANcer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 69495, Pierre Bénite, France., Kamps-Hughes N; Fluxion Biosciences, Alameda, CA, USA., Geiguer F; Laboratoire de Biochimie Et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495, Pierre Bénite, France.; CIRculating CANcer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 69495, Pierre Bénite, France., Couraud S; CIRculating CANcer (CIRCAN) Program, Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Cancer Institute of Hospices Civils de Lyon, Lyon, France., Sarver B; Fluxion Biosciences, Alameda, CA, USA., Payen L; Laboratoire de Biochimie Et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon, 69495, Pierre Bénite, France.; CIRculating CANcer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute, 69495, Pierre Bénite, France., Ionescu-Zanetti C; Fluxion Biosciences, Alameda, CA, USA. cristian@fluxionbio.com.
Publikováno v:
Scientific reports [Sci Rep] 2021 May 24; Vol. 11 (1), pp. 10761. Date of Electronic Publication: 2021 May 24.
Autor:
Varela, Mar1,2 (AUTHOR) mvarela@iconcologia.net, Villatoro, Sergi1,2 (AUTHOR), Lorenzo, Daniel3,4 (AUTHOR) dlorenzo@bellvitgehospital.cat, Piulats, Josep Maria4,5 (AUTHOR), Caminal, Josep Maria3,4 (AUTHOR) mvarela@iconcologia.net
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 17, p3053. 18p.
Autor:
Garcia, J., Monjaret, F., Geiguer, F., Aurel, J.-P., Puisieux, A., Morel, A.P., Bardel, C., Vilchez, G., Brigitte, M., Couraud, S., Vigneron, A., Tourniaire, G., Payen-Gay, L.F.
Publikováno v:
In Annals of Oncology October 2019 30 Supplement 5:v13-v13
Autor:
Franchina, Marianna1 (AUTHOR), Cavalcoli, Federica2 (AUTHOR), Falco, Olga3 (AUTHOR), La Milia, Marta3 (AUTHOR), Elvevi, Alessandra1 (AUTHOR), Massironi, Sara1 (AUTHOR) sara.massironi@libero.it
Publikováno v:
Diagnostics (2075-4418). Jun2024, Vol. 14 Issue 12, p1289. 20p.
Autor:
Garcia J; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute; University of Lyon, Claude Bernard University, Cancer Research Center of Lyon., Barthelemy D; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute; University of Lyon, Claude Bernard University, Cancer Research Center of Lyon., Geiguer F; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute., Ballandier J; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute; University of Lyon, Claude Bernard University, Cancer Research Center of Lyon., Li KW; Biolidics Limited., Aurel JP; Biolidics Limited., Le Breton F; Institut de Pathologie Multisites des HCL-Site Sud, Hospices Civils de Lyon., Rodriguez-Lafrasse C; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon., Manship B; University of Lyon, Claude Bernard University, Cancer Research Center of Lyon., Couraud S; Acute Respiratory Disease and Thoracic Oncology Department, Lyon Sud Hospital, Hospices Civils de Lyon Cancer Institute; EMR-3738 Therapeutic Targeting in Oncology, Lyon Sud Medical Faculty, Lyon 1 University., Payen L; Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud, Hospices Civils de Lyon; Circulating Cancer (CIRCAN) Program, Hospices Civils de Lyon Cancer Institute; University of Lyon, Claude Bernard University, Cancer Research Center of Lyon; lea.payen-gay@univ-lyon1.fr.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2019 Aug 14 (150). Date of Electronic Publication: 2019 Aug 14.